Skip to main content
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes.
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.
Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria.
Cold shock domain-containing protein E1 is a posttranscriptional regulator of the LDL receptor.
In utero priming of highly functional effector T cell responses to human malaria.
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.
An OX40/OX40L interaction directs successful immunity to hepatitis B virus.
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.